RhumbLine Advisers
NUVL

RhumbLine Advisers’s Nuvalent NUVL Stock Holding History

RhumbLine Advisers’s Portfolio NUVL Stock Details NUVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.54M Buy
63,867
+30
+0% +$3.06K 0.01% 1262
2025
Q4 		$6.42M Sell
63,837
-1,375
-2% -$136K 0.01% 1269
2025
Q3 		$5.64M Sell
65,212
-817
-1% -$64.6K ﹤0.01% 1365
2025
Q2 		$5.04M Buy
66,029
+13,003
+25% +$951K ﹤0.01% 1409
2025
Q1 		$3.76M Buy
53,026
+2,572
+5% +$201K ﹤0.01% 1498
2024
Q4 		$3.95M Buy
50,454
+1,896
+4% +$177K ﹤0.01% 1539
2024
Q3 		$4.97M Buy
48,558
+1,947
+4% +$161K ﹤0.01% 1431
2024
Q2 		$3.54M Buy
46,611
+7,420
+19% +$528K ﹤0.01% 1588
2024
Q1 		$2.94M Buy
39,191
+1,876
+5% +$149K ﹤0.01% 1698
2023
Q4 		$2.75M Buy
37,315
+2,466
+7% +$153K ﹤0.01% 1752
2023
Q3 		$1.6M Buy
34,849
+2,078
+6% +$92.2K ﹤0.01% 1968
2023
Q2 		$1.38M Buy
32,771
+456
+1% +$17.2K ﹤0.01% 2123
2023
Q1 		$843K Buy
32,315
+3,695
+13% +$109K ﹤0.01% 2204
2022
Q4 		$852K Buy
28,620
+3,611
+14% +$101K ﹤0.01% 2220
2022
Q3 		$486K Buy
25,009
+1,362
+6% +$22.8K ﹤0.01% 2502
2022
Q2 		$321K Buy
23,647
+8,442
+56% +$89.3K ﹤0.01% 2717
2022
Q1 		$211K Buy
+15,205
New +$221K ﹤0.01% 2742

Other funds holding NUVL

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RhumbLine Advisers's NUVL Position: Q1 2026 in Review

RhumbLine Advisers increased its Nuvalent (NUVL) stake by 0.05% in Q1 2026, buying an estimated $3.06K and bringing the position to 63,867 shares worth $6.54M. The position accounts for 0.01% of the portfolio, ranked #1262.

RhumbLine Advisers first reported a position in NUVL in Q1 2022 and has held it in 17 quarters since. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

  • RhumbLine Advisers held 63,867 shares of Nuvalent worth $6.54M as of Q1 2026.
  • RhumbLine Advisers bought 30 Nuvalent shares in Q1 2026, an estimated $3.06K.
  • Nuvalent made up 0.01% of RhumbLine Advisers's portfolio in Q1 2026, its #1262 holding.
  • RhumbLine Advisers first reported a position in Nuvalent in Q1 2022 and has held it in 17 quarters since.
  • 263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.